Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel

Pacira BioSciences (NASDAQ: PCRX) posted great revenue growth when it reported its quarterly results in February. Heading into the first quarter, investors were wondering if Pacira would be able to keep the momentum going.